Biocair Expands APAC Footprint with New Shanghai Office to Meet Soaring Life Science Logistics Demand
07 August 2025 | Thursday | News
Marking 25% H1 growth in the region, the UK-based logistics leader doubles its Shanghai footprint—strategically located near Pudong Airport and Pharma Valley—to bolster operations, client support, and end-to-end cold chain services across Asia.
Biocair, an established global leader in life science logistics, announces the further expansion of its operations in the APAC region with the opening of a new office in Shanghai, China. The office is collocated with its warehouse to facilitate operations and enable enhanced collaboration between operations, sales, warehouse and transportation teams. Biocair has achieved 25% business growth in APAC in the first half of 2025 and, with double the footprint of Biocair’s previous Shanghai office, the new site will support the company’s ongoing growth.
Biocair first opened a Shanghai office in 2009 as its primary APAC location and has since opened a further seven offices in the region. This new office is strategically located near Pudong International Airport as well as Pharma Valley in the Zhangjiang High Tech Zone. Following the recent opening of Biocair’s Chengdu office, this expansion further strengthens Biocair’s presence in the region and its position as a leading global logistics provider.
“The APAC region continues to show strong demand for comprehensive life science supply chain solutions. This new office in Shanghai will enable the Biocair team to continue to support our growing portfolio of APAC clients, as well as our global clients looking to ship goods to the region,” Kevin Xu, APAC General Manager.
Biocair’s dedicated Shanghai team of logistics experts provide comprehensive knowledge of the APAC region including customs regulations and the local transport network. The company offers a full range of temperature controlled logistics services, including controlled ambient (15-25°C), refrigerated (2-8°C), frozen (-20°C), dry ice (-78°C) and Liquid Nitrogen dry shipper (-196°C). The team will also continue to build on Biocair’s presence in the region, strengthening business development activities. Biocair is committed to investing in its global network in order to provide complete end-to-end logistics solutions as part of its global growth strategy.
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
